Adverts

Open Access Articles- Top Results for 2CB-Ind

2CB-Ind

</th></tr>
2CB-Ind
File:2CB-ind structure.png
Systematic (IUPAC) name
(5-bromo-4,7-dimethoxy-2,3-dihydro-1H-inden-1-yl)methanamine
Clinical data
  • Uncontrolled
Oral
Identifiers
912342-23-5 7pxN
None
PubChem CID 16086368
ChemSpider 17245022 7pxY
ChEMBL CHEMBL424890 7pxY
Chemical data
Formula C12H16BrNO2
286.164 g/mol
 14pxN (what is this?)  (verify)

2CB-Ind is a conformationally-restricted derivative of the phenethylamine hallucinogen 2C-B, discovered in 1974 by Alexander Shulgin. It acts as a moderately potent and selective agonist for the 5-HT2A and 5-HT2C receptors, but unlike the corresponding benzocyclobutene derivative TCB-2 which is considerably more potent than the parent compound 2C-B, 2CB-Ind is several times weaker, with racemic 2CB-Ind having a Ki of 47nM at the human 5-HT2A receptor, only slightly more potent than the mescaline analogue (R)-jimscaline.[1][2]

See also

References

  1. McLean, TH et al. (2006). "1-Aminomethylbenzocycloalkanes: conformationally restricted hallucinogenic phenethylamine analogues as functionally selective 5-HT2A receptor agonists". Journal of Medical Chemistry 49 (19): 5794–803. PMID 16970404. doi:10.1021/jm060656o. 
  2. Braden, Michael Robert (2007). Towards a biophysical understanding of hallucinogen action (PhD.). Purdue University. 


Lua error in package.lua at line 80: module 'Module:Buffer' not found.